Found 7 matching trials
Safety and Immunogenicity of PCV-LITE, a Low-dose of Pneumococcal Conjugate Vaccine With LiteVax Adjuvant PHASE1 Streptococcus pneumoniae is a common bacteria and major cause of serious in...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Learn About the Safety of PREVENAR 20 Vaccine in Infants Aged Between Two to Six Months N/A The purpose of this study is to learn about the safety of 20-valent Pneumoc...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Immunogenicity and Safety PCV-20 of the Vaccine Administered During an Acute Febrile Illness in Adults PHASE4 Streptococcus pneumoniae is responsible for serious infections associated t...
Show More Location
CHU de Saint-Etienne
Learn More & Join Trial
Safety and Immunogenicity of PCV20 in Pediatric Patients With Autoimmune Rheumatic Diseases PHASE4 This clinical trial evaluates the immunogenicity (humoral and cellular) and...
Show More Location
Hospital das Clinics da Faculdade de Medicina da Universidade de Sao Paulo
Learn More & Join Trial
A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market N/A The purpose of this study is to understand the safety of Prevenar 20 (Pneum...
Show More Learn More & Join Trial
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies PHASE3 BEATRIX (group B strEptococcus mATeRnal and Infant VaX study) The purpose o...
Show More Location
Center for Research in Women's Health
Learn More & Join Trial
Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma PHASE4 The French Public Health Council recommended pneumococcal vaccination combi...
Show More Learn More & Join Trial